Immuneering (IMRX) Property, Plant & Equipment (Net) (2020 - 2026)
Immuneering (IMRX) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | 642,333.36 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | 5.32 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | 1.64 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | 1.61 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | 5.27 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 518.26 Mn |
| 10 | Immuneering | 281.91 Mn | 281.91 Mn | - | 937,008.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 937,008.00 |
| Mar 31, 2026 | 937,008.00 |
| Dec 31, 2025 | 938,481.00 |
| Dec 31, 2025 | 938,481.00 |
| Sep 30, 2025 | 892,553.00 |
| Sep 30, 2025 | 892,553.00 |
| Jun 30, 2025 | 964,138.00 |
| Jun 30, 2025 | 964,138.00 |
| Mar 31, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Dec 31, 2023 | 1.40 Mn |